Search results
Author(s):
Bogdan A Popescu
,
Carmen C Beladan
,
Carmen Ginghina
Added:
3 years ago
Chronic heart failure (CHF) is a major cause of morbidity and mortality in the general population with a prevalence of 1–2% in developed countries, where it accounts for 1–2% of total healthcare resources. Therefore, the economic burden of HF may become unmanageable, indicating the need for cost-effective preventative strategies and treatments.1 It has been acknowledged that about 50% of patients…
View more
Author(s):
Cesare Rusconi
Added:
3 years ago
With the widespread availability of non-invasive bedside assessment of ventricular function by echocardiography in the last two decades the paradigm of heart failure (HF), presumed to be usually due to an impaired left ventricular (LV) systolic function, has been challenged by the finding that about half of patients suffering from HF syndrome exhibit a normal LV ejection fraction (LVEF), and the…
View more
Author(s):
Tarun Pandey
,
Kedar Jambhekar
Added:
3 years ago
Diastolic dysfunction and diastolic heart failure (DHF) have shown a steady increase in prevalence over the course of the last decade.1 DHF is now regarded as a major public health concern. It shows an increasing trend with age and exceeds the incidence rate of systolic heart failure by the eighth decade of life.2 In fact, it is estimated that approximately 25–30% of individuals 45 years of age…
View more
Author(s):
David Playford
Added:
3 years ago
Prof David Playford (The University of Notre Dame, Perth, AU) discusses diastolic function and mortality in 436,360 individuals using findings from the National Echo Database of Australia (NEDA).
Questions:
1. What are the objectives behind NEDA?
2. What findings did you present at ESC?
3. What were the methods of the study?
4. What were the study’s results?
5. What conclusions can be made?
6…
View more
Author(s):
Ilias Kanellos
Added:
4 years ago
Dr Ilias Kanellos (Ahepa University Hospital, Thessaloniki, GR) discusses therapeutic approaches via blood transfusion in anaemic patients with diastolic heart failure.
Filmed on site at HFA 2019 by Radcliffe Cardiology.
Videography: Mike Knight & Tom Green
Interviewer: Liam O'Neill
View more
Statin Therapy in Patients with Diastolic Heart Failure - Time for a Large, Randomised Study?
Author(s):
Marek Roik
,
Malgorzata H Starczewska
,
Grzegorz Opolski
Added:
3 years ago
Article
Author(s):
Desak Ketut Sekar Cempaka Putri
,
Andrianto Andrianto
,
Makhyan Jibril Al-Farabi
,
et al
Added:
1 year ago
Author(s):
Otto A Smiseth
,
Anders Opdahl
,
Espen Boe
,
et al
Added:
3 years ago
Abstract
Heart failure with preserved left ventricular ejection fraction (HF-PEF), sometimes named diastolic heart failure, is a common condition most frequently seen in the elderly and is associated with arterial hypertension and left ventricular (LV) hypertrophy. Symptoms are attributed to a stiff left ventricle with compensatory elevation of filling pressure and reduced ability to increase…
View more
Author(s):
Gilles W De Keulenaer
,
Dirk L Brutsaert
Added:
3 years ago
Definitions and Historical Considerations – The Misleading Role of Ejection Fraction
Chronic heart failure (CHF) is a heterogeneous syndrome with a complex pathophysiology. Although many different definitions for heart failure exist, we prefer the following: “a clinical syndrome characterised by symptoms and signs of increased tissue/organ water and decreased tissue/organ perfusion. Regardless…
View more
Author(s):
Kristian Wachtell
Added:
3 years ago
Left ventricular (LV) hypertrophy is a form of pre-clinical cardiac disease that may be induced by either pressure or volume myocardial overload, as well as genetic factors and a variety of other stimuli. Pressure overload, as exemplified by aortic stenosis, and volume overload, as exemplified by regurgitant aortic or mitral valve disease or chronic anaemia, initiates growth of cardiac myocytes…
View more